HWN Suggests

Meningococcemia Presentation

Aside from the initial symptoms that lack great sensitivity and the overt signs of badness that are hard to miss, there are also three other findings that have been associated with Meningococcemia. These take an active mind and vigilant clinician to detect and link to the potentially severe disease. Leg Pain. Found to have a 94.3% specificty! That is as good as neck stiffness! The patient may refuse to walk. The patient may merely report thigh pain. This may be due to inflammatory mediators that are being released by the immune system. Cold Hands and Feet. Abnormal Skin Color...

read full article

Featured

 Uncovering Meningococcemia: A Case Study in Reducing Risk in an Emergency Department

Timely recognition and management of life-threatening conditions are essential in emergency medicine. However, diagnosing such conditions can be challenging, particularly when symptoms are nonspecific or atypical. This case underscores the value of digital tools, such as VisualDx, in augmenting intelligence and optimizing patient outcomes in the Emergency Department setting.

Articles of Interest

Sick young person with spots - Meningococcemia in the ED

Alex and Venk talk through a previous case where they care for a young person with meningococcemia on a night shift. We review the disease, what to watch for, how to treat it, and go over some of the residue after being part of a case like this. We also review some of the considerations regarding ECMO for severe sepsis.

Meningococcemia in Adults: A Review of the Literature

The various consequences of severe meningococcal sepsis include hypotension, disseminated intravascular coagulation (DIC), multiple organ failure, and osteonecrosis due to DIC. The gold standard for the identification of meningococcal infection is the bacteriologic isolation of N. meningitidis from body fluids such as blood, cerebrospinal fluid (CSF), synovial fluid, and pleural fluid. Blood, CSF, and skin biopsy cultures are used for diagnosis.

Meningococcemia: Epidemiology, Pathophysiology, and Management

Meningococcemia is a rare but devastating disease that affects primarily the pediatric population. The virulence of Neisseria meningitidis is 100 times that of other gram-negative organisms, making prompt recognition and treatment essential to prevent significant morbidity and mortality. Management of these patients in the pediatric intensive care unit is a challenge and requires skilled clinicians, high level technology, and novel therapies.

Meningococcemia: rare but life-threatening

N. meningitidis is a Gram-negative bacteria that can be highly pathogenic in humans, the only host. Since 2008, the European incidence rate of meningococcal disease is 0.68/100 000, with the highest cases among children younger than 5 years. Concerning invasive disease, serogroup B is the most common, followed by serogroup C. In these cases, early antibiotics, aggressive initial shock approach and precocious referral to intensive care are potential factors with impact on reducing its mortality.

Pathogenesis of Meningococcemia

Neisseria meningitidis is responsible for two major diseases: cerebrospinal meningitis and/or septicemia. The latter can lead to a purpura fulminans, an often-fatal condition owing to the associated septic shock. These two clinical aspects of the meningococcal infection are consequences of a tight interaction of meningococci with host endothelial cells

Purpura fulminans

Meningococcemia is characterized by an abrupt onset of fever and rash. The rash is identified by petechiae, which are the most common sign, occurring in 50% to 60% of patients with meningococcemia. Purpura fulminans, a widespread ecchymosis and gangrene of the extremities, is a clinical manifestation of acute meningococcal septicemia.

The Fight Against Bacterial Meningitis And Meningococcemia Isn't Over

Anyone who’s spent time on a college campus has likely heard a lot about bacterial meningitis in recent years. Adolescents and young adults already have a higher susceptibility to this type of infection than other age groups — except infants — and the crowded environment of college can increase that risk. That said, anyone can come down with bacterial meningitis, or the related and more fatal meningococcemia, which is caused by the bacteria Neisseria meningitidis. Both of these are forms of what the medical profession calls meningococcal disease. Bacterial meningitis tends to be more severe than viral meningitis, and it can escalate rapidly if not properly diagnosed and treated.

The Sick Meningitis Patient – From Bad to Worse

These patients will have the classic petechial/purpuric rash on presentation 50% of the time. The most deadly form of skin involvement secondary to meningococcal infection is purpura fulminans, an acquired, often fatal, coagulopathy characterized by extensive skin involvement which rapidly progresses to skin necrosis with disseminated intravascular coagulation (DIC). These patients will benefit from fresh frozen plasma (FFP) (10-20 ml/kg every 8 hours) and/or protein C concentrate (100-120 units/kg initial bolus).

Resources

Life in the Fastlane

Rx - cefotaxime 100mg/kg LD -> 50mg/kg Q6hrly, -> ceftriaxone 100mg/kg IV OD, -> high dose penicillin 2million units Q2 hourly (adults), -> chloramphenicol, -> amoxicillin 75mg/Kg Q6hrly + cefotaxime for kids < 3 months – limb fasciotomies Underlying cause -> the place of all of these are uncertain.

NORD

Meningococcemia is a rare infectious disease characterized by upper respiratory tract infection, fever, skin rash and lesions, eye and ear problems, and possibly a sudden state of extreme physical depression (shock) which may be life-threatening without appropriate medical care. There are two forms of meningococcemia. Fluminant meningococcemia develops very rapidly and is more severe than chronic meningococcemia, which has a waxing and waning course.

StatPearls

Meningococcemia is a severe and potentially life-threatening infection of the bloodstream caused by Neisseria meningitidis, which can manifest as meningitis, septicemia, or both. The infection begins with asymptomatic nasopharynx colonization, followed by transmission through respiratory droplets requiring close contact. Infants and adolescents are the most vulnerable due to waning maternal antibodies and high nasopharyngeal colonization rates, respectively. Clinically, meningococcemia presents with fever, hemorrhagic rash, and signs of circulatory collapse, often progressing rapidly to septic shock.